2015 - Healthcare for Women Over 40

Content Origination Date: Apr 22, 2015 ‐ Content Expiration Date: May 15, 2018


Total CE Credits:
29.00 - Physician
29.00 - RN / NP (All RNs/Nurses except CA RNs)
29.00 - CA RN/CA BRN
7.25 - Pharmacology


The latest research will be translated into clinical pearls and evidence-based approaches for assessing and managing a variety of issues related to perimenopause, menopause and aging will be explored in sessions from this online conference.

Program Manager: Pam Jenkins-Wallace, MS, NP

Disclosures: The Program Manager has nothing to disclose.

Standard: $330.00

Sessions

Preview Available

Vulvar Dermatoses and Vulvodynia (Rx = .25 hr.)

Content Origination Date: Apr 22, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe the classification system used to categorize epithelial changes in the vulva.
  • Identify different infectious causes of vulvar complaints in women. 
  • Explain the neurological causes of vulvar pain. 

Speaker(s): Disclosures
  • Bayer, Agile, Grants/Research; Actavis, Bayer Merck, Honoraria/Speakers Bureau; Pfizer, Teva, Honoraria/Speakers Bureau; Actavis, Agile, Bayer, ContraMed, Consultant/Advisory Board;  Merck, Teva, MicroCHIPS, PharmaNest, Consultant/Advisory Board
Standard: $15.00

Preview Available

Common and Uncommon Neoplastic Genital Lesions: Test Your Skills!

Content Origination Date: Apr 22, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe common clinical presentation for VIN and VAIN. 
  • Outline the evaluation criteria needed for neoplastic lesions on the vulva. 
  • Explain appropriate staging and treatments for each category of neoplastic lesion. 

Speaker(s): Disclosures
  • Bayer, Agile, Grants/Research; Actavis, Bayer Merck, Honoraria/Speakers Bureau; Pfizer, Teva, Honoraria/Speakers Bureau; Actavis, Agile, Bayer, ContraMed, Consultant/Advisory Board;  Merck, Teva, MicroCHIPS, PharmaNest, Consultant/Advisory Board
Standard: $15.00

Preview Available

Hormone Therapy Update: The Latest on Products and Protocols (Rx= .5 hr.)

Content Origination Date: Apr 23, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Demonstrate familiarity with available hormonal treatments for menopause. 
  • Display understanding of when to use a progestin as part of hormone therapy. 
  • List 3 treatment options for symptoms of genital tract thinning. 

Speaker(s): Disclosures
  • Teva (ParaGard, LeCette, Contraception), Advisory Board; Actavis (Levosert IUD in development), Advisory Board; Teva (ParaGard), Speakers' Bureau; Merck (Nexplanon, Gardasil, NuvaRing, Contraception), Speakers' Bureau; Bayer (Mirena, Skyla), Speakers' Bureau
Standard: $15.00

Preview Available

Mood Disorders in Menopause: Behavioral and Pharmacologic Management (Rx = .5 hr.) - Faculty Panel (Rx = .25 hr.)

Content Origination Date: Apr 23, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Identify and understand the pathophysiology and different clinical presentations of mood disorders in Menopause.
  • Select and prescribe medication/s that target the patient’s symptoms so that the patient will gain remission.
  • Identify psychological and social dimensions of patients’ mood disorder leading to appropriate psychotherapy and/or support for the patient.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Sexuality and the Older Woman: What Are the Issues?

Content Origination Date: Apr 23, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Identify new terminology for VVA or genital syndrome of menopause.
  • Develop a differential diagnosis for vaginal dryness and sexual pain syndromes.
  • Formulate a treatment paradigm that will enable HCP to effectively manage these medical conditions.

Speaker(s): Disclosures
  • Palatin technologies, Consultant, advisory Board; Shinogi, Consultant, speaker bureau, advisory board; Sprout, Consultant, advisory Board; Noven, Consultant, speaker bureau, advisory board; Viveve Medical, Consultant, speaker bureau, advisory board
Standard: $15.00

Preview Available

Breast Cancer Prevention: Personalized Approach to Lifestyle and Pharmacologic Strategies (Rx = .25 hr.) - Q&D - Faculty Panel

Content Origination Date: Apr 23, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe a personalized approach to evaluating risk, including family history, risk factors and calculating risk using available models.
  • Discuss risk reduction strategies related to lifestyle behaviors.
  • Discuss risk reduction strategies related to pharmacologic options.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Contraceptive Options for Women Over 40 (Rx = 1 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Display familiarity with sections of the 2010 CDC US Medical Eligibility for Contraceptive Use that pertain to older women. 
  • Identify 2 considerations when counseling older women about contraception. 
  • Describe 3 “non-contraceptive benefits” that could benefit perimenopausal woman. 

Speaker(s): Disclosures
  • Teva (ParaGard, LeCette, Contraception), Advisory Board; Actavis (Levosert IUD in development), Advisory Board; Teva (ParaGard), Speakers' Bureau; Merck (Nexplanon, Gardasil, NuvaRing, Contraception), Speakers' Bureau; Bayer (Mirena, Skyla), Speakers' Bureau
     
Standard: $15.00

Preview Available

Managing Irregular Bleeding in Perimenopause (Rx = .5 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe the causes of infrequent, frequent, heavy and prolonged bleeding in this period.
  • Describe interventions to reduce abnormal uterine bleeding in perimenopausal women. 
  • Outline plans for evaluation of abnormal uterine bleeding. 

Speaker(s): Disclosures
  • Bayer, Agile, Grants/Research; Actavis, Bayer Merck, Honoraria/Speakers Bureau; Pfizer, Teva, Honoraria/Speakers Bureau; Actavis, Agile, Bayer, ContraMed, Consultant/Advisory Board;  Merck, Teva, MicroCHIPS, PharmaNest, Consultant/Advisory Board
     
Standard: $15.00

Preview Available

Managing Non-Responders to Osteoporosis Therapy: What Now? (Rx = .5 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Participants will be able to distinguish responders from non-responders to osteoporosis medication.
  • Participants will understand the various causes for non-response to osteoporosis medications.
  • Participants will be able to discuss treatment choices in patients who do not respond to initial treatment.

Speaker(s): Disclosures
  • Amgen, Consultant
Standard: $15.00

Preview Available

Healthy Aging: Focus on Nutrition, Exercise and Mind-Body Health

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Review evidence for current nutrition advice for women. 
  • Discuss the importance of exercise in women's health. 
  • Introduce Mind-Body practices as a component of healthy aging. 

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Getting Enough ZZZs: Improving Sleep Quality (Rx = .5 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Understand the important role of sleep in physical and mental health and incorporate the newest advances in our understanding of sleep promoting and wake promoting systems in the brain.
  • Identify the risks of co-morbidity of insomnia with mood and anxiety disorders in order to enhance early diagnosis and prevention as well as the best treatment for your patients.
  • Describe and incorporate the behavioral and pharmacological recommendations for enhancing sleep and sleep quality as well as looking at treatments on the near horizon.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Emerging Pharmacology for Sexual Disorders: What's New and What's Coming (Rx = .75 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe the differential differences in drug development between men and women.
  • Discuss emerging sexual pharmacology for HSDD including flibanserin and bremelanotide.
  • Discuss early medications and combination medications that are in early development.

Speaker(s): Disclosures
  • Palatin technologies, Consultant, advisory Board; Shinogi, Consultant, speaker bureau, advisory board; Sprout, Consultant, advisory Board; Noven, Consultant, speaker bureau, advisory board; Viveve Medical, Consultant, speaker bureau, advisory board
     
Standard: $15.00

Preview Available

Non-Surgical Approach to Pelvic Floor Relaxation

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Describe risks factors for pelvic floor relaxation.
  • Identify preventive measures to address weakened pelvic muscles. 
  • Identify the role of physical therapy modalities in toning and improving pelvic muscle function. 

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Counseling Women at High Risk for Breast Cancer

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Identify women at high risk for breast cancer.
  • Describe options they have for monitoring and reducing risk of developing breast cancer.
  • Review counseling strategies to support women at risk.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

The Pocket Endocrinologist: How to Tackle (Not Punt) Common Metabolic Problems (Rx = .5 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Identify metabolic and endocrinology problems which may arise in older women.
  • Discuss the preliminary clinical assessment, diagnostic studies and initial interventions for selected endocrinology problems in women.
  • Highlight when to refer selected endocrinopathies to an endocrinologist.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Polypharmacy in the Older Patient (Rx = .75 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Analyze cases involving the use of potentially inappropriate medications. 
  • Review the Beers Criteria. 
  • Identify steps to improve medication safety. 

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Introduction to Pessary Fitting

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Select an appropriate pessary for each individual woman. 
  • Examine a variety of pessaries and determine the conditions for which individual pessaries are indicated.
  • Counsel women on pessary use, risks and benefits. 

Speaker(s): Disclosures
  • Bayer, Agile, Grants/Research; Actavis, Bayer Merck, Honoraria/Speakers Bureau; Pfizer, Teva, Honoraria/Speakers Bureau; Actavis, Agile, Bayer, ContraMed, Consultant/Advisory Board;  Merck, Teva, MicroCHIPS, PharmaNest, Consultant/Advisory Board
  • Teva (ParaGard, LeCette, Contraception), Advisory Board; Actavis (Levosert IUD in development), Advisory Board; Teva (ParaGard), Speakers' Bureau; Merck (Nexplanon, Gardasil, NuvaRing, Contraception), Speakers' Bureau; Bayer (Mirena, Skyla), Speakers' Bureau
Standard: $15.00

Preview Available

Supplements and Botanicals: When Our Patients Want Alternatives (Rx = .75 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Define Integrative Medicine. 
  • Review evidence for common supplements and botanicals in women's health. 
  • Review resources for navigating use of supplements and botanicals

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Endocrinology Update: The Aging Thyroid (Rx = .25 hr.)

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Highlight the changes in thyroid function as women age.
  • Discuss the preliminary clinical assessment, diagnostic studies and initial interventions for thyroid disorders.
  • Identify when to refer selected thyroid disorders to an endocrinologist.

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00

Preview Available

Cognitive Aging: Can We Alter the Course?

Content Origination Date: Apr 24, 2015 ‐ Content Expiration Date: May 15, 2018

CE Credits: None available.

Learning Objectives:

  • Identify normal and abnormal cognitive changes in aging. 
  • Evaluate the evidence for modifying cognitive aging. 
  • Consider strategies for maintaining cognitive health. 

Speaker(s): Disclosures
  • This speaker has nothing to disclose.
Standard: $15.00